Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: A clinical trial

European Respiratory Journal

Volumn 12, Issue 2, 1998, Pages 341-344

  Mangat, H S ^a,b   D'Souza, G A ^a   Jacob, M S ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute asthma; Emergency department; Nebulized magnesium sulphate; Peak expiratory flow

Indexed keywords

HYDROCORTISONE; MAGNESIUM SULFATE; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; HYPOTENSION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREMOR;

EID: 0031868056     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12020341     Document Type: Article

References (30)

1. Sly RM. Stabilization of asthma mortality. Ann Allergy Asthma Immunol 1997; 78: 347-354.
2. Schuh S, Parkin P, Rajan A, et al. High versus low dose frequently administered nebulised albuterol in children with severe acute asthma. Paediatrics 1989; 83: 513-518.
3. Colacone A, Wolkove N, Stern E, et al. Continuous nebulisation of albuterol in acute asthma. Chest 1990; 97: 693-697.
4. Siegal D, Sheppard D, Gelb A, Wiinberg PF. Aminophylline increases the toxicity but not the efficacy of an inhaled beta adrenergic agonist in the treatment of acute exacerbation of asthma. Am Rev Respir Dis 1985; 132: 282-286.
5. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effect of intravenous magnesium sulphate in bronchial asthma. JAMA 1987; 257: 1076-1078.
6. McNamara RM, Spivey WH, Skobeloff E, Jacubowitz S. Intravenous magnesium sulphate in the management of acute respiratory failure complicating asthma. Ann Emerg Med 1989; 18: 197-199.
7. Rosello JC, Pla JC. Sulfato de magnesio en la crisis de asma. Prensa Med Argent 1936; 23: 1677-1680.
8. Haury VG. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulphate. J Lab Clin Med 1940; 26: 340-341.
9. Leber MJ, Rao S, Birrer RB. Magnesium sulphate used as an adjunct to beta-agonists in acute asthma. J Emerg Med 1991; 9: 377-378.
10. Kuitert LM, Kletchko SL. Intravenous magnesium sulphate in acute life threatening asthma. Ann Emerg Med 1991; 20: 1243-1245.
11. Sydow M, Crozier TA, Zielmann S, Radke J, Burchardi H. High-dose intravenous magnesium sulphate in the management of life threatening status asthmaticus. Intensive Care Med 1993; 19: 467-471.
12. Skobeloff EM, Spivey WH, McNamara RM, Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989; 262: 1210-1213.
13. Barzo P, Biro P, Liptak E, Gyurcsik A, Barzo P Jr, Szabo T. Magnezium szulfat intravenas adasa utan bekovetkezo cardiorespiratorius es elektrolit valtozasok status asthmaticusban. Orv Hetil 1993; 134 (29): 1577-1580.
14. Noppen M, Vanmaele L, Impens N, Schandevyl W. Bronchodilating effect of intravenous magnesium sulphate in acute severe bronchial asthma. Chest 1990; 97: 373-376.
15. Rolla G, Bucca C, Brussino L, Colagrande P. Effect of intravenous magnesium infusion on salbutamol-induced bronchodilatation in patients with asthma. Magnes Res 1994; 7: 129-133.
16. Schiermeyer RP, Finkelstein JA. Rapid infusion of magnesium sulphate obviates need for intubation in status asthmaticus. Am J Emerg Med 1994; 12: 164-166.
17. Bloch H, Silverman R. Mancherje N, et al. Intravenous magnesium sulphate as an adjunct in the treatment of acute asthma. Chest 1995; 107: 1576-1581.
18. Chande VT, Skoner DP. A trial of nebulised magnesium sulphate to reverse bronchospasm in asthmatic patients. Ann Emerg Med 1992; 21: 1111-1115.
19. Rolla G, Bucca C, Bugiani M, Arossa W, Spinaci S. Reduction of histamine-induced bronchoconstriction by magnesium in asthmatic subjects. Allergy 1987; 42: 186-188.
20. Rolla G, Bucca C, Arossa W, Bugiani M. Magnesium attenuates methacholine induced bronchoconstriction in asthmatics. Magnesium 1987; 6: 201-204.
21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
22. Cropp GTM, Berntein JL, Boushey HH, et al. Guidelines for bronchial inhalation challenges with pharmacological and antigenic agents. ATS News, Spring 1980; pp. 11-19.
23. Fischl M, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalisation in patients with acute bronchial asthma. N Engl J Med 1981; 305: 783-789.
24. Jindal SK, Bansal S, Malik SK. Peak expiratory flow rate in healthy north Indian adults. Bull PGI 1974; 8: 2.
25. Martindale W. Magnesium Sulphate: Adverse Effects. The Extra Pharmacopoeia, 29th edn. London, The Pharmaceutical Press, 1989; p. 1033.
26. Altura BM, Altura BT, Carella A. Magnesium deficiency induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science 1983; 221: 376-378.
27. Bois P. Effect of magnesium deficiency on mast cells and urinary histamine in rats. Br J Exp Pathol 1963; 44: 151-155.
28. Kass RS, Lederer WJ, Tsin RW, et al. Role of calcium ions in transient inward currents and after contractions induced by strophanthidin in cardiac Purkinjee fibres. J Physiol 1978; 281: 187-208.
29. Dunnet J, Naylen WG. Calcium efflux from cardiac sarcoplasmic reticulum: effects of calcium and magnesium. J Mol Cell Cardiol 1978; 10: 487-498.
30. Del Castillo J, Engback L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124: 370-384.